US beauty biotech outfit Debut has signed an agreement with L'Oréal to develop more than a dozen bio-identical ingredients designed to replace conventionally sourced ingredients.
The conventional ingredients are currently used in L'Oréal global beauty and personal care brands across skin, hair, colour cosmetics and fragrance.
As part of the agreement, San Diego-based Debut will create new bio-based ingredients using proprietary advanced biomanufacturing processes that combine fermentation and cell-free technology to replace conventional methods.
“Creating bio-identical ingredients at scale helps preserve global biodiversity and secure responsible ingredient supply chains while continuing to prioritize quality and product performance," said Debut Founder and CEO Joshua Britton (pictured).
“Debut is committed to creating bio-based formulations for all its beauty products and has unmatched capabilities in biotechnology, formulation and scaling to catalyze this transformative shift in beauty,” he added.
Guive Balooch, global managing director of augmented beauty and open innovation at L'Oréal, said: “Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet.
“This long-term agreement with Debut is another example of our commitment to the Open Innovation ecosystem and building the future of beauty by collaborating with best-in-class partners.”
